Throughout 2019, SAP has helped to spread the Enable Injections story and the potential for the enFuse to impact patients. We are delighted to be partnering with SAP and leveraging their software solutions as we grow, scale, and prepare for commercialization.
Enable Injections CFO, Tim Flaherty, has appeared many times at SAP events to share the Enable story. In addition, SAP produced a video sharing the patient perspective.
Watch the 2-minute video by clicking here.
This week, the enFuse story appeared on Forbes.com. Please read below for the link and an excerpt written by Tricia Manning-Smith, SAP:
This Pharma Startup Could Transform How Chronic Diseases Are Treated
By Tricia Manning-Smith, SAP
The needle is so tiny, you almost have to hold it up to the light to see it. It’s the size of three hairs held together. This miniscule needle, and its supporting medical technology, might change the future for many chronic disease patients.
Yet, because the needle is hidden inside an unprecedented med-tech device, patients will never actually see it. A patient will stick the yo-yo sized device on her abdomen and the needle stays hidden inside. She then simply pushes a button to self-administer her medication.
“There’s nothing like it in the world,” said Tim Flaherty, CFO and spokesman for Enable Injections. He explains that the startup company’s device is currently undergoing clinical trials before attaining the final FDA approval.
Flaherty shows the device to visitor Megan Starshak, a chronic disease sufferer, as they tour the company’s Cincinnati, Ohio-based research and production facility. “The device doesn’t feel clinical and scary,” said Starshak. She knows a great deal about needles and pain.
When Starshak was 18, a doctor diagnosed her with the chronic autoimmune disease, Ulcerative Colitis (similar to Crohn’s Disease). Since then, Megan has tried every treatment available to ease her symptoms, which include chronic fatigue, urgent bowel movements and abdominal pain.
“My highest pill count per day was 28,” said Starshak who now visits a clinic for a nurse-administered IV that injects medication directly into her veins. “At the time, the IV was my last option to avoid surgery.”